Effect of labrafil 2125CS on the oral bioavailability of danazol, a poorly soluble drug compound
Research output: Contribution to conference › Poster › Research
Standard
Effect of labrafil 2125CS on the oral bioavailability of danazol, a poorly soluble drug compound. / Larsen, Anne; Holm, Rene; Pedersen, Mette; Müllertz, Anette.
2007. Poster session presented at 3rd world congress of the board of pharmaceutical sciences of FIP, Amsterdam, Netherlands.Research output: Contribution to conference › Poster › Research
Harvard
Larsen, A, Holm, R, Pedersen, M & Müllertz, A 2007, 'Effect of labrafil 2125CS on the oral bioavailability of danazol, a poorly soluble drug compound', 3rd world congress of the board of pharmaceutical sciences of FIP, Amsterdam, Netherlands, 22/04/2007 - 25/04/2007.
APA
Larsen, A., Holm, R., Pedersen, M., & Müllertz, A. (2007). Effect of labrafil 2125CS on the oral bioavailability of danazol, a poorly soluble drug compound. Poster session presented at 3rd world congress of the board of pharmaceutical sciences of FIP, Amsterdam, Netherlands.
Vancouver
Larsen A, Holm R, Pedersen M, Müllertz A. Effect of labrafil 2125CS on the oral bioavailability of danazol, a poorly soluble drug compound. 2007. Poster session presented at 3rd world congress of the board of pharmaceutical sciences of FIP, Amsterdam, Netherlands.
Author
Bibtex
@conference{668bbc308e0411dd9c20000ea68e967b,
title = "Effect of labrafil 2125CS on the oral bioavailability of danazol, a poorly soluble drug compound",
author = "Anne Larsen and Rene Holm and Mette Pedersen and Anette M{\"u}llertz",
year = "2007",
language = "English",
note = "null ; Conference date: 22-04-2007 Through 25-04-2007",
}
RIS
TY - CONF
T1 - Effect of labrafil 2125CS on the oral bioavailability of danazol, a poorly soluble drug compound
AU - Larsen, Anne
AU - Holm, Rene
AU - Pedersen, Mette
AU - Müllertz, Anette
N1 - Conference code: PSWC2007
PY - 2007
Y1 - 2007
M3 - Poster
Y2 - 22 April 2007 through 25 April 2007
ER -
ID: 6317864